Quantcast
Last updated on April 16, 2014 at 11:21 EDT

Latest General anesthetics Stories

2011-05-12 15:15:00

CUPERTINO, Calif., May 12, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Matt Hogan, Chief Financial Officer, will be presenting at the UBS Global Specialty Pharmaceuticals Conference on Tuesday, May 24 at 10:00 a.m. London Time. The conference is being held at the UBS offices in London, England (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2011-05-10 06:30:00

REDWOOD CITY, Calif., May 10, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, announced that the opposition period for a patent granted by the European Patent Office expired on April 21 and to date there is no indication that the patent has been opposed. The patent (European patent EP2114383), covers...

2011-04-28 07:00:00

CUPERTINO, Calif., April 28, 2011 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) first quarter 2011 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, May 5, 2011 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2011-04-27 12:34:00

CHICAGO, April 27, 2011 /PRNewswire/ -- The First District of the Illinois Court of Appeals has received final briefing in the appeal of a $16.56 million judgment entered more than two years ago against Johnson & Johnson (NYSE: JNJ) subsidiaries Janssen Pharmaceutica Inc. and ALZA Corp. The appeal stems from a Nov. 17, 2008, jury verdict in Judge Thomas Flanagan's Cook County Circuit Court. Jurors found Janssen and ALZA liable in the death of a 38-year-old wife and mother of three in...

2011-03-21 08:50:00

LOS ANGELES, March 21, 2011 /PRNewswire/ -- Attorneys from Dallas' Heygood, Orr & Pearson are announcing a Los Angeles Superior Court ruling that will require executives from Watson Pharmaceuticals Inc. (NYSE: WPI) and its subsidiary companies to testify under oath and produce key documents as part of a lawsuit over the death of a 37-year-old woman who died while using the company's fentanyl patch. Attorney Michael Heygood represents the parents of Nicole Bristol, who died on Feb. 9,...

2011-03-01 15:15:00

CUPERTINO, Calif., March 1, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Dr. James E. Brown, President and Chief Executive Officer, will be presenting at the Cowen and Company 31st Annual Healthcare Conference on Monday, March 7 at 1:00 pm Eastern Time. The conference is being held at the Marriott Copley Place in Boston. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing...

2011-02-24 15:30:00

CUPERTINO, Calif., Feb. 24, 2011 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2010 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Wednesday, March 2, 2011 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2011-02-07 16:30:00

CUPERTINO, Calif., Feb. 7, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Matt Hogan (Chief Financial Officer) will be presenting at the BIO CEO & Investor Conference on Monday, February 14 at 9:30 a.m. Eastern Time. The conference is being held at the Waldorf-Astoria Hotel in New York City. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2011-01-17 08:53:00

READING, England, January 17, 2011 /PRNewswire/ -- Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium (SMC) to accept PecFent(R) (fentanyl pectin nasal spray) for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain. Following the SMC clinical effectiveness and health economic review...

2011-01-04 00:00:37

An expert on the use of propofol who has been interviewed by leading publications on the death of Michael Jackson is confident Dr. Conrad Murray will be ordered to stand trial at the Jan. 4 preliminary hearing in Los Angeles County Superior Court. "There is no question in my mind but that the prosecution will be able to establish probable cause that Dr. Murray should stand trial in the death of Michael Jackson," predicts Dr. Barry Friedberg, M.D. and author of Getting Over Going Under: 5...